Limbach Holdings Appoints David Gaboury to Board

Limbach Holdings, a building systems solutions firm, has made significant changes to its Board of Directors in its latest announcement. David Gaboury has been elected to the Board, bringing over 40 years of experience in the engineering industry. This move comes as the company aims to leverage his expertise to support its strategy of becoming the premier pure-play provider of building systems solutions.

Gaboury's impressive background includes serving as the Board Chair, CEO, and President of Terracon, where he oversaw substantial growth with annual revenue increasing from $75 million to $750 million. He also held leadership roles in various professional, not-for-profit, and civic organizations. His appointment follows the retirement of Norbert W. Young, who served on the Board for nearly eight years.

In addition to Gaboury's election, Joshua S. Horowitz has been appointed Chairman of the Board, succeeding Gordon G. Pratt, who will remain on the Board as Chairman Emeritus. These changes aim to leverage the broad expertise and experience of each Board member.

The company's shift in leadership comes amidst its focus on partnering with building owners and facilities managers in various vertical markets, including healthcare, industrial and manufacturing, data centers, life science, higher education, and cultural and entertainment. With more than 1,300 team members in 19 offices across the eastern United States, Limbach aims to provide essential services that are crucial to the operation of their customers' businesses.

The changes in the Board composition and leadership reflect the company's commitment to driving overall growth and expansion. This strategic move aligns with Limbach's goal of being an indispensable partner to its customers by providing custom solutions that address both operational and capital project needs.

Today the company's shares have moved 0.2% to a price of $59.76. For the full picture, make sure to review Limbach's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.